XML 34 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Investments
6 Months Ended
Jul. 31, 2011
Investments [Abstract]  
INVESTMENTS
NOTE 4 — INVESTMENTS
     We have an investment in Banfield which is accounted for using the equity method of accounting. Our ownership interest in the stock of Banfield was as follows (in thousands):
                                                 
    July 31, 2011     January 30, 2011     August 1, 2010  
    Shares     Amount     Shares     Amount     Shares     Amount  
Voting common stock and preferred stock
    4,693     $ 21,675       4,693     $ 21,675       4,693     $ 21,675  
Equity in income from Banfield
          26,541             21,183             14,368  
Dividend received from Banfield
          (15,960 )                        
 
                                   
Total equity investment in Banfield
    4,693     $ 32,256       4,693     $ 42,858       4,693     $ 36,043  
 
                                   
     Our investment consisted of voting common stock, comprising 21.4% of all voting stock as of July 31, 2011, January 30, 2011, and August 1, 2010. Our ownership percentage as of July 31, 2011, January 30, 2011, and August 1, 2010, considering all classes of stock (voting and non-voting) was 21.0%.
     Banfield’s financial data is summarized as follows (in thousands):
                         
    July 31, 2011     January 30, 2011     August 1, 2010  
Current assets
  $ 340,116     $ 351,379     $ 314,625  
Noncurrent assets
    128,942       119,175       122,987  
Current liabilities
    332,841       279,836       278,683  
Noncurrent liabilities
    11,257       12,367       15,932  
                                 
    Thirteen Weeks Ended     Twenty-Six Weeks Ended  
    July 31, 2011     August 1, 2010     July 31, 2011     August 1, 2010  
Net sales
  $ 176,428     $ 161,346     $ 341,286     $ 310,654  
Income from operations
    23,532       16,929       44,919       28,646  
Net income
    13,250       10,096       25,512       16,940  
     We recognized license fees and reimbursements for specific operating expenses from Banfield of $9.1 million and $8.6 million during the thirteen weeks ended July 31, 2011, and August 1, 2010, respectively, and $18.1 million and $16.8 million during the twenty-six weeks ended July 31, 2011, and August 1, 2010, respectively, in other revenue on the Condensed Consolidated Statements of Income and Comprehensive Income. The related costs are included in cost of other revenue in the Condensed Consolidated Statements of Income and Comprehensive Income. Receivables from Banfield totaled $3.1 million, $2.7 million and $3.0 million at July 31, 2011, January 30, 2011, and August 1, 2010, respectively, and were included in receivables, net in the Condensed Consolidated Balance Sheets.
     The master operating agreement also includes a provision for the sharing of profits on the sale of therapeutic pet foods sold in all stores with an operating Banfield hospital. The net sales and gross profit on the sale of therapeutic pet food are not material to our condensed consolidated financial statements.